<DOC>
	<DOCNO>NCT00029224</DOCNO>
	<brief_summary>Patients bone metastases bone lesion cause breast cancer , multiple myeloma prostate cancer treat IV Zometa 15 minute infusion . Pain evaluate , well time chair , quality life safety Zometa .</brief_summary>
	<brief_title>Treatment With Zoledronic Acid Patients With Breast Cancer , Multiple Myeloma , Prostate Cancer With Cancer Related Bone Lesions</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Inclusion Criteria Signed inform consent Greater 18 year age Proof breast cancer , multiple myeloma prostate cancer Diagnosis least one cancerrelated bone lesion If patient childbearing potential , negative pregnancy test medically recognize form contraception ECOG performance status 0,1 2 Ability read , understand write English Spanish language Normal renal function Corrected serum calcium equal great 8mg/dl Exclusion Criteria clinically symptomatic brain metastasis hypersensitivity Zometa bisphosphonates pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>bone lesion</keyword>
	<keyword>breast cancer</keyword>
	<keyword>multiple myeloma</keyword>
	<keyword>prostate cancer</keyword>
	<keyword>bone metastasis</keyword>
	<keyword>pain</keyword>
</DOC>